Basel Medical (BMGL) Receivables (2024 - 2025)

Basel Medical (BMGL) posted Receivables of $12.1 million for Q4 2025, up 610.41% sequentially from $1.7 million in Q2 2025, and down 22.21% YoY from $15.6 million in Q4 2024.

Basel Medical (BMGL) Receivables (2024 - 2025) Analysis & Trends

Basel Medical (BMGL) has 2 years of Receivables data on file, last reported at $12.1 million in Q4 2025.

  • Quarterly Receivables fell 22.21% year-over-year to $12.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.1 million (down 22.21% YoY) and the FY2025 annual result came in at $1.7 million, up 20.17% from the prior year.
  • Receivables improved to $12.1 million in Q4 2025 per BMGL's latest filing, from $1.7 million in the prior quarter.
  • The five-year high for Receivables was $15.6 million in Q4 2024, with the low at $1.4 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn 11.32 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 215.48 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 2.81 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn 2.98 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn 676.00 Mn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn 663.25 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn 2.75 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn 666.30 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn 16.38 Mn
10 Basel Medical 133.19 Mn 130.39 Mn - 12.12 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 12.12 Mn
Jun 30, 2025 1.71 Mn
Dec 31, 2024 15.58 Mn
Jun 30, 2024 1.39 Mn